I think Gerald knows he must get off the OTC and o
Post# of 30028
Posted On: 09/04/2014 2:59:50 PM
I think Gerald knows he must get off the OTC and onto the NASDAQ before year end. The pps probably will be higher than .15 cents come November when he does a RS, but I am just saying that in the worst case scenario, I am comfortable starting the RS & up list process even at .15 cents.
Big Pharma is playing hard ball with Gerald. He doesn't want to give away the store. This deal with ICON allows us to commercialize LymPro with all those Research companies doing AD clinical trials and will generate enough revenue in the first half of 2015 that it will rocket our pps upward, even without a partnership on LymPro or MANF.
Once BP sees us doing just fine bringing in revenue on our own, they will give Gerald what he asks for, not just for LymPro but for a MANF partnership for Retinitis or Diabetes, as well.
ICON wasn't what we were hoping for, but it definitely keeps us moving the ball down the field. I'm good. I say we stop trying to kiss up to Big Pharma. Lets just go do our thing. Start up LymPro revenue, get orphan designation for MANF on a couple indications, start Eltoprazine phase 2b trial, and up list. I think Gerald should play hard to get and cut off communications with BP.
By next summer we'll be doing so well they'll be coming onto the message boards begging shareholders who have communication lines with Gerald to please use their influence with him to get Gerald to return their phone calls!!
Screw Big Pharma, we'll be fine on our own for now.
It's all about having the goods and having attitude! I think Gerald has both!!
Big Pharma is playing hard ball with Gerald. He doesn't want to give away the store. This deal with ICON allows us to commercialize LymPro with all those Research companies doing AD clinical trials and will generate enough revenue in the first half of 2015 that it will rocket our pps upward, even without a partnership on LymPro or MANF.
Once BP sees us doing just fine bringing in revenue on our own, they will give Gerald what he asks for, not just for LymPro but for a MANF partnership for Retinitis or Diabetes, as well.
ICON wasn't what we were hoping for, but it definitely keeps us moving the ball down the field. I'm good. I say we stop trying to kiss up to Big Pharma. Lets just go do our thing. Start up LymPro revenue, get orphan designation for MANF on a couple indications, start Eltoprazine phase 2b trial, and up list. I think Gerald should play hard to get and cut off communications with BP.
By next summer we'll be doing so well they'll be coming onto the message boards begging shareholders who have communication lines with Gerald to please use their influence with him to get Gerald to return their phone calls!!
Screw Big Pharma, we'll be fine on our own for now.
It's all about having the goods and having attitude! I think Gerald has both!!
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼